Health Trials

Resveratrol Effects on Inflammatory Biomarkers and Cardiometabolic Parameters.

ConditionsInflammation BiomarkersCardiometabolic Health IndicatorsAntioxidant Status, InflammationAntioxidant CapabilitiesInflammaging
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorCenter for Research and Innovation Viña Concha y Toro

About this trial

This study aims to evaluate the effect of the supplementation of grape pomace bars enriched in resveratrol on inflammatory biomarkers and cardiometabolic parameters in community-dwelling adults

Eligibility criteria

Qualifiers

Comunnity-dwelling persons.

Any ethnicity.

With willingness to consume the bar daily during the intervention period.

Disqualifiers

Allergy/intolerance to ingredients in the bar.

Pregnancy or breastfeeding.

Use of antioxidant/polymeroid supplements in the last 4 weeks.

Unstable chronic diseases (e.g., severe liver failure, advanced kidney failure, active cancer).

Trial design

Treatments tested in this trial

  • RES 120
  • RES 250
  • RES 500

Treatment groups

75 Participants
are divided into 3 treatment groups

Sponsors and collaborators

Center for Research and Innovation Viña Concha y Toro

Lead sponsor

Universidad Católica del Maule

Collaborator

Source ClinicalTrials.gov